{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:00:29Z","timestamp":1792555229227,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.kint.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:24:07Z","timestamp":1682655847000},"page":"343-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Proprotein convertase subtilisin\/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use"],"prefix":"10.1016","volume":"104","author":[{"given":"Sanjeev","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Casal Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Debiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samih H.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LouAnn","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Negron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman Deep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany N.","family":"Caza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJM199802123380707","article-title":"Analgesic nephropathy","volume":"338","author":"De Broe","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.04.006_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.04.006_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2023.04.006_bib4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.08090719","article-title":"NSAIDs and nephrotic syndrome","volume":"14","author":"M\u00e9rida","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.04.006_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2215\/CJN.14331218","article-title":"Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users","volume":"14","author":"Bakhriansyah","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/pgmj.68.799.392","article-title":"Membranous nephropathy associated with diclofenac","volume":"68","author":"Tattersall","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.kint.2023.04.006_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/oxfordjournals.ndt.a091897","article-title":"Reversible membranous nephritis associated with diclofenac","volume":"4","author":"Campistol","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.04.006_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/exostosin 2\u2013associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.04.006_bib12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B\u2013associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1681\/ASN.2020081165","article-title":"Protocadherin 7-associated membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1681\/ASN.0000000000000061","article-title":"Membranous nephropathy in syphilis is associated with neuron-derived neurotrophic factor","volume":"34","author":"Sethi","year":"2023","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib17","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A\u00a0statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.kint.2023.04.006_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jcp.23.7.629","article-title":"Elution of antibodies from biopsy tissue","volume":"23","author":"Feltkamp","year":"1970","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.kint.2023.04.006_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.04.006_bib21","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1681\/ASN.2020101395","article-title":"Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy","volume":"32","author":"Al-Rabadi","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.04.006_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.04.006_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000519912","article-title":"The prevalence of mesangial electron-dense deposits in PLA2R-positive membranous nephropathy","volume":"146","author":"Giannini","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj3210587","article-title":"PACE4: a subtilisin-like endoprotease with unique properties","volume":"321","author":"Mains","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.kint.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1570-9639(02)00532-0","article-title":"Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix","volume":"1645","author":"Tsuji","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2023.04.006_bib27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1101\/gad.14.9.1146","article-title":"SPC4\/PACE4 regulates a TGF\u03b2 signaling network during axis formation","volume":"14","author":"Constam","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2023.04.006_bib28","article-title":"Proprotein convertase subtilisin\/kexin 6 in cardiovascular biology and disease","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2023.04.006_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.119.316063","article-title":"PCSK6 is a key protease in the control of smooth muscle cell function in vascular remodeling","volume":"126","author":"Rykaczewska","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2023.04.006_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3899\/jrheum.140435","article-title":"Inhibition of PCSK6 may play a protective role in the development of rheumatoid arthritis","volume":"42","author":"Wang","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2023.04.006_bib31","first-page":"289","article-title":"Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer","volume":"29","author":"Page","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.kint.2023.04.006_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958121","article-title":"Proprotein convertases and the complement system","volume":"13","author":"Dob\u00f3","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.04.006_bib33","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.4049\/jimmunol.2000636","article-title":"Proprotein convertase is the highest-level activator of the alternative complement pathway in the blood","volume":"206","author":"Oroszl\u00e1n","year":"2021","journal-title":"J\u00a0Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823003125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823003125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:05:06Z","timestamp":1758762306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823003125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0085253823003125"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.04.006","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proprotein convertase subtilisin\/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}